Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications

Abstract excerpt

BACKGROUND: Despite several studies suggesting a potential oligogenic risk model in amyotrophic lateral sclerosis (ALS), case-control statistical evidence implicating oligogenicity with disease risk or clinical outcomes is limited. Considering its direct clinical and therapeutic implications, we aim to perform a large-scale robust investigation of oligogenicity in ALS risk and in the disease clinical course....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amyotrophic Lateral Sclerosis Research
• Share to Hereditary Neurological Disorders
• Share to Neurogenetic and Muscular Disorders Research